Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Nov 2022 for NexImmune, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John Trainer: trading record in brief
John Trainer, listed as finance chief, appears in our data through filings on NexImmune, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 8 April 2021 to 22 November 2022.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 25 November 2022, reports a share grant in NexImmune, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John Trainer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
125,200 shares0Common StockSEC:0001209191-22-058801:0
3,432 shares@ €4.363620.2% of flowCommon StockSEC:0001209191-21-046170:0
3,432 shares@ €4.247219.7% of flowCommon StockSEC:0001209191-21-039163:0
3,432 shares@ €4.338820.1% of flowCommon StockSEC:0001209191-21-033999:0
4 of 4 declarations
